Metabolic Syndrome and the Risk of Adverse Cardiovascular Events After Acute Coronary Syndrome

Metabolic syndrome (MetS) represents a cluster of interrelated risk factors, including central obesity, hypertension, dyslipidemia, and impaired glucose metabolism, that collectively increase cardiovascular risk. Although metabolic syndrome is well known to contribute to the development of atherosclerotic cardiovascular disease, its incremental prognostic value following an acute coronary syndrome (ACS) remains uncertain. This article summarizes the findings of Cavallari et al. (2018), who evaluated the prognostic role of metabolic syndrome in patients following ACS.